期刊
VASCULAR
卷 15, 期 6, 页码 372-375出版社
B C DECKER INC
DOI: 10.2310/6670.2007.00057
关键词
anticoagulants; heparin; thrombin; vascular disease
After more than 70 years of effective clinical use, heparin remains the most common anticoagulant in use and one of the most commonly prescribed drugs to hospitalized patients. However, the biologic variability and immunogenicity limit its utility. With increasing volumes of vascular intervention and an aging population, an increase in the need for anticoagulation can be anticipated. This article reviews current viable options and barriers to the use of heparin.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据